Document is current

Any future updates will be listed below

Author Correction: Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease

Crossref DOI link: https://doi.org/10.1038/s41598-021-90075-z

Published Online: 2021-05-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark